arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

RenovoRx, Inc.

RNXT

$1.20 ▼ -0.11 (-8.78%) at close

7 Visible periods

23 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

RenovoRx, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $42.4M

Dividend Yield —

Revenue Growth 2511.6%

Op. Margin —

ROIC -230.8% ↘

FCF / Share $-0.31 ↗

Trailing P/E —

Price / Book 8.1x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

7-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$1.12M

↑ +2511.6% —

Net Income Profit after all expenses

$-11.17M

↓ -26.7% —

FCF / Share Free cash flow per share

$-0.31

↑ +24.3% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns

Financial Health ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Revenue Growth YoY (%)	2511.6% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+31295%)	—	—	—	—	—	—
EPS Growth YoY (%)	20.0% Good ↓ Good Declining Year-over-year change in earnings per share Optimal: > 10%	59.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	9.2% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	9.9% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	—	—	—
Net Income Growth YoY (%)	-26.7% Weak ↓ Weak Declining Year-over-year change in net income	13.9% Fair ↑ Fair Improving Year-over-year change in net income	-3.5% Weak ↑ Weak Improving Year-over-year change in net income	-56.4% Weak Weak Year-over-year change in net income	-66.5% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	24.3% Good → Good Stable Year-over-year change in free cash flow	58.8% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-2.4% Weak Weak Year-over-year change in free cash flow	14.2% Fair Fair Year-over-year change in free cash flow	—	—	—

💰 Are margins durable? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Effective Tax Rate (%) (%)	-0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—
FCF / Net Income (x)	0.98x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	1.04x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	1.00x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.94x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	-230.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-193.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	300.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-127.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-29.2% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	17.3% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-154.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-135.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-777.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-137.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-34.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	-167.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	-206.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1473%)	-196.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1412%)	—	-160.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1170%)	-41.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-375%)	25.9% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+73%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Interest Coverage (x)	-781.88x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-522.38x Weak Weak Operating income divided by interest expense Optimal: > 5x	-814.00x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	-5.46x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-7.02M	$-7.15M	$-1.17M	$-4.39M	$-15.19M	$-1.79M	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Revenue per Share (USD)	$0.03	$0.00	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.32	$-0.40	$-0.99	$-1.09	$-1.21	—	—
Free Cash Flow per Share (USD)	$-0.31	$-0.41	$-1.00	$-0.97	$-1.13	—	—
Book Value per Share (USD)	$0.15	$0.19	$-0.28	$0.68	$1.72	$-6.56	—
Tangible Book Value per Share (USD)	$0.15	$0.19	$-0.28	$0.68	$1.72	$-6.56	—
Basic Weighted Avg Shares (shares)	35.33M	22.27M	10.29M	9.05M	5.22M	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$5.93M	$5.92M	$291.00K	—	—	$-2.19M	—
Total Equity (USD)	$5.42M	$4.48M	$-3.00M	$6.16M	$15.35M	$-14.66M	$-10.93M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Sales/Revenue/Turnover (USD)	$1.12M	$43.00K	—	—	—	—	—
Depreciation Expense (USD)	$2.00K	$0.00	—	—	—	—	—
Net Income, GAAP (USD)	$-11.17M	$-8.81M	$-10.23M	$-9.89M	$-6.32M	$-3.80M	—
Operating Cash Flow (USD)	$-10.97M	$-9.12M	$-10.26M	$-8.81M	$-5.92M	$-3.53M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 7 years · 27 quarters

RenovoRx, Inc.

Analytical Summary

7-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare RNXT with peers